Yi Yu

1.5k total citations · 1 hit paper
33 papers, 1.1k citations indexed

About

Yi Yu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yi Yu has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Yi Yu's work include Cancer, Lipids, and Metabolism (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and RNA modifications and cancer (4 papers). Yi Yu is often cited by papers focused on Cancer, Lipids, and Metabolism (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and RNA modifications and cancer (4 papers). Yi Yu collaborates with scholars based in China, United States and United Kingdom. Yi Yu's co-authors include Qian Lü, Yuyan Xiong, Fanglin Niu, Xiling Zhao, Xueyi Chen, Yan Yuan, Ping Liu, Yuru Liu, Yajun Wang and Yuanyuan Ren and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Yi Yu

29 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases

2021 518 citations Yi Yu, Yan Yuan et al. Cell Death Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Yu China	12	584	355	297	117	112	33	1.1k
Fanglin Niu China	11	425 0.7×	326 0.9×	305 1.0×	112 1.0×	101 0.9×	38	882
Hao Zheng China	19	786 1.3×	375 1.1×	370 1.2×	102 0.9×	72 0.6×	46	1.2k
Christudas Morais Australia	19	483 0.8×	309 0.9×	205 0.7×	73 0.6×	145 1.3×	60	1.0k
Mengqi Guo China	16	885 1.5×	504 1.4×	472 1.6×	165 1.4×	181 1.6×	34	1.4k
Étienne Audet‐Walsh Canada	23	682 1.2×	389 1.1×	399 1.3×	67 0.6×	157 1.4×	58	1.4k
Yuguang Zhao China	18	531 0.9×	230 0.6×	163 0.5×	107 0.9×	201 1.8×	54	1.3k
Paula Sotomayor United States	22	658 1.1×	307 0.9×	246 0.8×	139 1.2×	298 2.7×	32	1.3k
Agnieszka Gomułkiewicz Poland	21	454 0.8×	206 0.6×	203 0.7×	125 1.1×	318 2.8×	61	1.0k

Countries citing papers authored by Yi Yu

Since Specialization

Citations

This map shows the geographic impact of Yi Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Yu more than expected).

Fields of papers citing papers by Yi Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Yu. The network helps show where Yi Yu may publish in the future.

Co-authorship network of co-authors of Yi Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Yu. A scholar is included among the top collaborators of Yi Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Yu. Yi Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Yi, et al.. (2025). Nomogram for predicting postoperative recurrence in patients with microvascular invasion-negative hepatocellular carcinoma: development and validation. Frontiers in Immunology. 16. 1614392–1614392.

Wang, Xiaoli, Yi Yu, Zhiwei Xu, et al.. (2025). Treatment patterns for chronic obstructive pulmonary disease under the tiered medical system. Scientific Reports. 15(1). 844–844. 2 indexed citations

Liang, Rui, Yang Li, Qingyun Yang, et al.. (2025). Hydrogen sulfide revisited: a stealthy ally in the unseen war against cardiovascular disease. Biochemical Pharmacology. 244. 117577–117577.

Li, Ranran, Xuhui Huang, Yongtao Liu, et al.. (2025). AKT/mTOR/BDNF pathway mediates the antidepressant-like effects of NAc-DBS in a mouse model of depression. Frontiers in Behavioral Neuroscience. 19. 1662449–1662449. 1 indexed citations

Luo, You, et al.. (2025). Ferroptosis: a novel therapeutic warrior in the battle against leukemia. APOPTOSIS. 30(7-8). 1776–1795.

Li, Yang, Fanglin Niu, Zhuozhuo Li, et al.. (2024). RNA-binding protein GIGYF2 orchestrates hepatic insulin resistance through STAU1/PTEN-mediated disruption of the PI3K/AKT signaling cascade. Molecular Medicine. 30(1). 124–124. 7 indexed citations

Yu, Yi, et al.. (2023). Myo1b Promotes Premature Endothelial Senescence and Dysfunction via Suppressing Autophagy: Implications for Vascular Aging. Oxidative Medicine and Cellular Longevity. 2023. 1–19. 4 indexed citations

Li, Yang, Zhuozhuo Li, Yuanyuan Ren, et al.. (2023). Mitochondrial-derived peptides in cardiovascular disease: Novel insights and therapeutic opportunities. Journal of Advanced Research. 64. 99–115. 22 indexed citations

Niu, Fanglin, Zhuozhuo Li, Yuanyuan Ren, et al.. (2023). Aberrant hyper-expression of the RNA binding protein GIGYF2 in endothelial cells modulates vascular aging and function. Redox Biology. 65. 102824–102824. 12 indexed citations

10.

Yu, Yi, Mingjie Zhu, Jie Yang, et al.. (2022). Age-related differential gene expression in granulosa cells and its effects on fertility using high-throughput transcriptomics. Systems Biology in Reproductive Medicine. 68(3). 190–202. 3 indexed citations

11.

Niu, Fanglin, Yi Yu, Zhuozhuo Li, et al.. (2022). Arginase: An emerging and promising therapeutic target for cancer treatment. Biomedicine & Pharmacotherapy. 149. 112840–112840. 103 indexed citations

12.

Ren, Yuanyuan, et al.. (2022). Arginase: Biological and Therapeutic Implications in Diabetes Mellitus and Its Complications. Oxidative Medicine and Cellular Longevity. 2022(1). 2419412–2419412. 22 indexed citations

13.

Ye, Shuai, Martin G. Belinsky, Jeffrey M. Farma, et al.. (2021). Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor. Cancers. 13(15). 3699–3699. 4 indexed citations

14.

Yu, Yi, Yan Yuan, Fanglin Niu, et al.. (2021). Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discovery. 7(1). 193–193. 518 indexed citations breakdown →

15.

Kostaras, Eleftherios, Teresa Kaserer, Pedro Casado, et al.. (2020). A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity. British Journal of Cancer. 123(4). 542–555. 29 indexed citations

16.

Li, Diangeng, Peng Wang, Yi Yu, et al.. (2018). Tumor-preventing activity of aspirin in multiple cancers based on bioinformatic analyses. PeerJ. 6. e5667–e5667. 9 indexed citations

17.

Nandan, Devki, Yi Yu, Brian Schwartz, et al.. (2018). Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against Leishmania. PLoS ONE. 13(11). e0206920–e0206920. 20 indexed citations

18.

Kim, Kyungho, Jing Li, Alan Tseng, et al.. (2016). ARQ 092, an orally-available, selective AKT inhibitor, attenuates neutrophil-platelet interactions in sickle cell disease. Haematologica. 102(2). 246–259. 24 indexed citations

19.

Yu, Yi, Ronald E. Savage, Sudharshan Eathiraj, et al.. (2015). Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092. PLoS ONE. 10(10). e0140479–e0140479. 103 indexed citations

20.

Yu, Yi, Xiuli Jiang, Bradley S. Schoch, et al.. (2007). Aberrant Splicing of Cyclin-Dependent Kinase–Associated Protein Phosphatase KAP Increases Proliferation and Migration in Glioblastoma. Cancer Research. 67(1). 130–138. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact